Myomo (MYO) EPS (Basic) Growth (3y) (2019 - 2025)
Myomo (MYO) EPS (Basic) Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 19.63% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 50.64% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -6.23% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 29.56% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 11.31% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1,801.39% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 17.98% |
| 10 | Myomo | 73.79 Mn | 54.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 39.92% |
| Jun 30, 2025 | 35.76% |
| Mar 31, 2025 | 41.09% |
| Dec 31, 2024 | 61.29% |
| Sep 30, 2024 | 58.72% |
| Jun 30, 2024 | 59.88% |
| Mar 31, 2024 | 43.23% |
| Dec 31, 2023 | 40.40% |
| Sep 30, 2023 | 56.62% |
| Jun 30, 2023 | 68.15% |
| Mar 31, 2023 | 64.84% |
| Dec 31, 2022 | 59.43% |
| Sep 30, 2022 | 56.53% |
| Jun 30, 2022 | 54.63% |
| Mar 31, 2022 | 60.86% |
| Dec 31, 2021 | 55.51% |
| Sep 30, 2021 | 61.62% |
| Jun 30, 2021 | 58.19% |
| Mar 31, 2021 | 54.14% |
| Dec 31, 2020 | 66.20% |